Bamifylline
From Wikipedia, the free encyclopedia
![]() |
|
![]() |
|
Names | |
---|---|
IUPAC name
8-Benzyl-7-{2-[ethyl(2-hydroxyethyl)amino]ethyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
Identifiers | |
2016-63-9 ![]() |
|
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL2110760 ![]() |
ChemSpider | 15401 ![]() |
ECHA InfoCard | 100.116.522 |
PubChem | 16229 |
UNII | ZTY15D026H ![]() |
|
|
|
|
Properties | |
C20H27N5O3 | |
Molar mass | 385.46008 |
Pharmacology | |
R03DA08 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Bamifylline is a drug of the xanthine chemical class which acts as a selective adenosine A1 receptor antagonist.[1][2]
See also[edit]
References[edit]
- ^ Tomai, F; Crea, F; Gaspardone, A; Versaci, F; De Paulis, R; Polisca, P; Chiariello, L; Gioffrè, PA (June 1996). "Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty" (PDF). European Heart Journal. 17 (6): 846–53. PMID 8781823.
- ^ Kofman, J; Grosclaude, M; Ouechni, MM; Perrin-Fayolle, M. "Comparative effects of bamifylline and theophylline on allergenic bronchospasm induced by the provocative inhalation test: double-blind cross-over study". Le Poumon et le Cœur (in French). 38 (3): 197–202. PMID 6752929.
![]() |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |